| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0007 |